Airway protein levels of both inhibitors were observed to negatively correlate with NE activity in CF patients, suggesting that as SLPI concentrations decrease, NE protease activity increases, which subsequently may promote TIMP-1 degradation in these samples, in agreement with previous studies (20). Here, ELANE is linked to cystic fibrosis.